Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
Conditions: Acute Myeloid Leukemia Interventions: Biological: CD4CAR Sponsors: Huda Salman Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
Conditions: Metastatic Castration-resistant Prostate Cancer Interventions: Biological: MSGV1-PSCA-8T28Z; Drug: Fludarabine; Drug: Cyclophosphamide Sponsors: H. Lee Moffitt Cancer Center and Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
Conditions: Epidermolysis Bullosa Dystrophica Interventions: Other: Sampling Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL
Conditions: Lymphoblastic Leukemia; Philadelphia-Positive ALL; Adult ALL Interventions: Drug: Vincristine; Drug: Dexamethasone; Drug: Imatinib; Drug: Cytarabine; Drug: Mercaptopurine; Drug: Methotrexate; Drug: Ponatinib; Procedure: allogeneic stem cell transplantation; Procedure: Total body irradiation; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: PETHEMA Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy
Conditions: Critical Limb Ischemia Interventions: Procedure: UCA-PSCs/bFGF or bFGF Intramuscular injection Sponsors: Nanjing University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: MSC Interventions: Biological: mesenchymal stromal cells Sponsors: ShiCang Yu; Xinqiao Hospital of Chongqing Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Conditions: Ganglioneuroblastoma; Neuroblastoma Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration; Procedure: Bone Marrow Biopsy; Procedure: Bone Scan; Drug: Carboplatin; Drug: Cisplatin; Procedure: Computed Tomography; Drug: Cyclophosphamide; Drug: Dexrazoxane; Biological: Dinutuximab; Drug: Doxorubicin; Drug: Etoposide; Procedure: FDG-Positron Emission Tomography and Computed Tomography Scan; Procedure: Hematopoietic Cell Transplantation; Drug: Irinotecan; Drug: Isotretinoin; Procedure: Leukapheresis; Procedure: Magnetic Resonance Imaging; Drug: Melphalan; Radiation: Radiation Therapy; O...
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma
Conditions: Glioma, Malignant; New Diagnosis Tumor Interventions: Biological: NSC-CRAd-S-pk7; Dietary Supplement: N-acetylcysteine amide (NACA) Sponsors: Northwestern University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Effect of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD
Conditions: End-stage Liver Diseases Interventions: Biological: umbilical cord-mesenchymal stem cells Sponsors: General Hospital of Shenyang Military Region Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy Study of hAESCs Therapy for aGVHD
Conditions: GVHD,Acute Interventions: Drug: Human Amniotic Epithelial Stem Cell Injection Sponsors: Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Horizons Chronic Graft-Versus-Host-Disease Study
Conditions: Graft Vs Host Disease; Coping Skills; Quality of Life; Stem Cell Transplant Complications Interventions: Behavioral: Horizons Group Intervention Sponsors: University of Miami Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Stem Cell Study for Long COVID-19 Neurological Symptoms
Conditions: Post-Acute COVID-19 Syndrome Interventions: Biological: Stem Cell Sponsors: Charles Cox; CBR Systems, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
Conditions: Leukemia; Stem Cell Transplant; Cord Blood Interventions: Procedure: applying of FLU+CY post-HSCT Sponsors: Nanfang Hospital, Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Cell Therapy and Myocardial Recovery in Heart Failure Patients Undergoing Left Ventricular Assist Device Support
Conditions: Heart Failure; Mechanical Circulatory Support Interventions: Biological: CD34+ stem cell therapy Sponsors: University Medical Centre Ljubljana Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing
Conditions: Mesenchymal Stem Cells Interventions: Biological: Mesenchymal Stem Cells (MSCs) Sponsors: Southwest Hospital, China; Xinqiao Hospital of Chongqing Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
